APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prevent Meningitis Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Prevent Meningitis Vaccine Market Analysis and Forecast 2026-2032

30 December 2025208 pages

Choose your research edition.

Industry ResearchPrevent Meningitis Vaccine Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Prevent Meningitis Vaccine Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Prevent Meningitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prevent Meningitis Vaccine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Prevent Meningitis Vaccine Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Prevent Meningitis Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Prevent Meningitis Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Prevent Meningitis Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Prevent Meningitis Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Prevent Meningitis Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Prevent Meningitis Vaccine include GSK, China National Biotec Group, Zhejiang Tianyuan, Sanofi Pasteur, Novartis, Merck, Tianjin CanSino Biotechnology, Pfizer and Hualan Bio, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Prevent Meningitis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Prevent Meningitis Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Prevent Meningitis Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prevent Meningitis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prevent Meningitis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Prevent Meningitis Vaccine sales, projected growth trends, production technology, application and end-user industry.

Prevent Meningitis Vaccine Segment by Company

GSK

China National Biotec Group

Zhejiang Tianyuan

Sanofi Pasteur

Novartis

Merck

Tianjin CanSino Biotechnology

Pfizer

Hualan Bio

Beijing Tiantan Biological

Baxter International

Zhifei

Wyeth Pharmaceuticals, Inc

Walvax

Serum Institute of India

JN International Medical Corporation

CSL Behring

Bio-Med

Prevent Meningitis Vaccine Segment by Type

Meningococcal AC Vaccine

Meningococcal A Vaccine

Meningococcal B Vaccine (MenB)

Meningococcal Conjugate Vaccine (MenaCWY)

Prevent Meningitis Vaccine Segment by Application

Baby

Teenager

Child

Others

Prevent Meningitis Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prevent Meningitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prevent Meningitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prevent Meningitis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Prevent Meningitis Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Prevent Meningitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prevent Meningitis Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prevent Meningitis Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Meningococcal AC Vaccine Major Manufacturers Table 3. Meningococcal A Vaccine Major Manufacturers Table 4. Meningococcal B Vaccine (MenB) Major Manufacturers Table 5. Meningococcal Conjugate Vaccine (MenaCWY) Major Manufacturers Table 6. Global Prevent Meningitis Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Baby Major Manufacturers Table 8. Teenager Major Manufacturers Table 9. Child Major Manufacturers Table 10. Others Major Manufacturers Table 11. Prevent Meningitis Vaccine Industry Trends Table 12. Prevent Meningitis Vaccine Industry Drivers Table 13. Prevent Meningitis Vaccine Industry Opportunities and Challenges Table 14. Prevent Meningitis Vaccine Industry Restraints Table 15. Global Prevent Meningitis Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Prevent Meningitis Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Prevent Meningitis Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2021-2026) Table 19. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2027-2032) Table 20. Global Prevent Meningitis Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Prevent Meningitis Vaccine Sales by Region (2021-2026) & (K Units) Table 22. Global Prevent Meningitis Vaccine Sales by Region (2027-2032) & (K Units) Table 23. Global Prevent Meningitis Vaccine Sales Market Share by Region (2021-2026) Table 24. Global Prevent Meningitis Vaccine Sales Market Share by Region (2027-2032) Table 25. Global Prevent Meningitis Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Prevent Meningitis Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Prevent Meningitis Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Prevent Meningitis Vaccine Sales Market Share by Manufacturers (2021-2026) Table 29. Global Prevent Meningitis Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Prevent Meningitis Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Prevent Meningitis Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Prevent Meningitis Vaccine Manufacturers, Product Type & Application Table 33. Global Prevent Meningitis Vaccine Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Prevent Meningitis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Prevent Meningitis Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Prevent Meningitis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Prevent Meningitis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Prevent Meningitis Vaccine Revenue Market Share by Type (2021-2026) Table 40. Global Prevent Meningitis Vaccine Revenue Market Share by Type (2027-2032) Table 41. Global Prevent Meningitis Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Prevent Meningitis Vaccine Sales by Type (2021-2026) & (K Units) Table 43. Global Prevent Meningitis Vaccine Sales by Type (2027-2032) & (K Units) Table 44. Global Prevent Meningitis Vaccine Sales Market Share by Type (2021-2026) Table 45. Global Prevent Meningitis Vaccine Sales Market Share by Type (2027-2032) Table 46. Global Prevent Meningitis Vaccine Price by Type (2021-2026) & (US$/Unit) Table 47. Global Prevent Meningitis Vaccine Price by Type (2027-2032) & (US$/Unit) Table 48. Global Prevent Meningitis Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Prevent Meningitis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Prevent Meningitis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Prevent Meningitis Vaccine Revenue Market Share by Application (2021-2026) Table 52. Global Prevent Meningitis Vaccine Revenue Market Share by Application (2027-2032) Table 53. Global Prevent Meningitis Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Prevent Meningitis Vaccine Sales by Application (2021-2026) & (K Units) Table 55. Global Prevent Meningitis Vaccine Sales by Application (2027-2032) & (K Units) Table 56. Global Prevent Meningitis Vaccine Sales Market Share by Application (2021-2026) Table 57. Global Prevent Meningitis Vaccine Sales Market Share by Application (2027-2032) Table 58. Global Prevent Meningitis Vaccine Price by Application (2021-2026) & (US$/Unit) Table 59. Global Prevent Meningitis Vaccine Price by Application (2027-2032) & (US$/Unit) Table 60. GSK Company Information Table 61. GSK Business Overview Table 62. GSK Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. GSK Prevent Meningitis Vaccine Product Portfolio Table 64. GSK Recent Development Table 65. China National Biotec Group Company Information Table 66. China National Biotec Group Business Overview Table 67. China National Biotec Group Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. China National Biotec Group Prevent Meningitis Vaccine Product Portfolio Table 69. China National Biotec Group Recent Development Table 70. Zhejiang Tianyuan Company Information Table 71. Zhejiang Tianyuan Business Overview Table 72. Zhejiang Tianyuan Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Zhejiang Tianyuan Prevent Meningitis Vaccine Product Portfolio Table 74. Zhejiang Tianyuan Recent Development Table 75. Sanofi Pasteur Company Information Table 76. Sanofi Pasteur Business Overview Table 77. Sanofi Pasteur Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Sanofi Pasteur Prevent Meningitis Vaccine Product Portfolio Table 79. Sanofi Pasteur Recent Development Table 80. Novartis Company Information Table 81. Novartis Business Overview Table 82. Novartis Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Novartis Prevent Meningitis Vaccine Product Portfolio Table 84. Novartis Recent Development Table 85. Merck Company Information Table 86. Merck Business Overview Table 87. Merck Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Merck Prevent Meningitis Vaccine Product Portfolio Table 89. Merck Recent Development Table 90. Tianjin CanSino Biotechnology Company Information Table 91. Tianjin CanSino Biotechnology Business Overview Table 92. Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product Portfolio Table 94. Tianjin CanSino Biotechnology Recent Development Table 95. Pfizer Company Information Table 96. Pfizer Business Overview Table 97. Pfizer Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Pfizer Prevent Meningitis Vaccine Product Portfolio Table 99. Pfizer Recent Development Table 100. Hualan Bio Company Information Table 101. Hualan Bio Business Overview Table 102. Hualan Bio Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Hualan Bio Prevent Meningitis Vaccine Product Portfolio Table 104. Hualan Bio Recent Development Table 105. Beijing Tiantan Biological Company Information Table 106. Beijing Tiantan Biological Business Overview Table 107. Beijing Tiantan Biological Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Beijing Tiantan Biological Prevent Meningitis Vaccine Product Portfolio Table 109. Beijing Tiantan Biological Recent Development Table 110. Baxter International Company Information Table 111. Baxter International Business Overview Table 112. Baxter International Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Baxter International Prevent Meningitis Vaccine Product Portfolio Table 114. Baxter International Recent Development Table 115. Zhifei Company Information Table 116. Zhifei Business Overview Table 117. Zhifei Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Zhifei Prevent Meningitis Vaccine Product Portfolio Table 119. Zhifei Recent Development Table 120. Wyeth Pharmaceuticals, Inc Company Information Table 121. Wyeth Pharmaceuticals, Inc Business Overview Table 122. Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product Portfolio Table 124. Wyeth Pharmaceuticals, Inc Recent Development Table 125. Walvax Company Information Table 126. Walvax Business Overview Table 127. Walvax Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Walvax Prevent Meningitis Vaccine Product Portfolio Table 129. Walvax Recent Development Table 130. Serum Institute of India Company Information Table 131. Serum Institute of India Business Overview Table 132. Serum Institute of India Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Serum Institute of India Prevent Meningitis Vaccine Product Portfolio Table 134. Serum Institute of India Recent Development Table 135. JN International Medical Corporation Company Information Table 136. JN International Medical Corporation Business Overview Table 137. JN International Medical Corporation Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. JN International Medical Corporation Prevent Meningitis Vaccine Product Portfolio Table 139. JN International Medical Corporation Recent Development Table 140. CSL Behring Company Information Table 141. CSL Behring Business Overview Table 142. CSL Behring Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. CSL Behring Prevent Meningitis Vaccine Product Portfolio Table 144. CSL Behring Recent Development Table 145. Bio-Med Company Information Table 146. Bio-Med Business Overview Table 147. Bio-Med Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Bio-Med Prevent Meningitis Vaccine Product Portfolio Table 149. Bio-Med Recent Development Table 150. North America Prevent Meningitis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 151. North America Prevent Meningitis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 152. North America Prevent Meningitis Vaccine Sales by Type (2021-2026) & (K Units) Table 153. North America Prevent Meningitis Vaccine Sales by Type (2027-2032) & (K Units) Table 154. North America Prevent Meningitis Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 155. North America Prevent Meningitis Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 156. North America Prevent Meningitis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 157. North America Prevent Meningitis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 158. North America Prevent Meningitis Vaccine Sales by Application (2021-2026) & (K Units) Table 159. North America Prevent Meningitis Vaccine Sales by Application (2027-2032) & (K Units) Table 160. North America Prevent Meningitis Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 161. North America Prevent Meningitis Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 162. North America Prevent Meningitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. North America Prevent Meningitis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. North America Prevent Meningitis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. North America Prevent Meningitis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 166. North America Prevent Meningitis Vaccine Sales by Country (2021-2026) & (K Units) Table 167. North America Prevent Meningitis Vaccine Sales by Country (2027-2032) & (K Units) Table 168. North America Prevent Meningitis Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 169. North America Prevent Meningitis Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 170. United States Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 171. Canada Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 172. Europe Prevent Meningitis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 173. Europe Prevent Meningitis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 174. Europe Prevent Meningitis Vaccine Sales by Type (2021-2026) & (K Units) Table 175. Europe Prevent Meningitis Vaccine Sales by Type (2027-2032) & (K Units) Table 176. Europe Prevent Meningitis Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 177. Europe Prevent Meningitis Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 178. Europe Prevent Meningitis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 179. Europe Prevent Meningitis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 180. Europe Prevent Meningitis Vaccine Sales by Application (2021-2026) & (K Units) Table 181. Europe Prevent Meningitis Vaccine Sales by Application (2027-2032) & (K Units) Table 182. Europe Prevent Meningitis Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 183. Europe Prevent Meningitis Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 184. Europe Prevent Meningitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Europe Prevent Meningitis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Europe Prevent Meningitis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Europe Prevent Meningitis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. Europe Prevent Meningitis Vaccine Sales by Country (2021-2026) & (K Units) Table 189. Europe Prevent Meningitis Vaccine Sales by Country (2027-2032) & (K Units) Table 190. Europe Prevent Meningitis Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 191. Europe Prevent Meningitis Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Germany Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 193. France Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 194. U.K. Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 195. Italy Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 196. Netherlands Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 197. China Prevent Meningitis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 198. China Prevent Meningitis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 199. China Prevent Meningitis Vaccine Sales by Type (2021-2026) & (K Units) Table 200. China Prevent Meningitis Vaccine Sales by Type (2027-2032) & (K Units) Table 201. China Prevent Meningitis Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 202. China Prevent Meningitis Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 203. China Prevent Meningitis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 204. China Prevent Meningitis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 205. China Prevent Meningitis Vaccine Sales by Application (2021-2026) & (K Units) Table 206. China Prevent Meningitis Vaccine Sales by Application (2027-2032) & (K Units) Table 207. China Prevent Meningitis Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 208. China Prevent Meningitis Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 209. Asia Prevent Meningitis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 210. Asia Prevent Meningitis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 211. Asia Prevent Meningitis Vaccine Sales by Type (2021-2026) & (K Units) Table 212. Asia Prevent Meningitis Vaccine Sales by Type (2027-2032) & (K Units) Table 213. Asia Prevent Meningitis Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 214. Asia Prevent Meningitis Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 215. Asia Prevent Meningitis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 216. Asia Prevent Meningitis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 217. Asia Prevent Meningitis Vaccine Sales by Application (2021-2026) & (K Units) Table 218. Asia Prevent Meningitis Vaccine Sales by Application (2027-2032) & (K Units) Table 219. Asia Prevent Meningitis Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 220. Asia Prevent Meningitis Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 221. Asia Prevent Meningitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. Asia Prevent Meningitis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. Asia Prevent Meningitis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. Asia Prevent Meningitis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 225. Asia Prevent Meningitis Vaccine Sales by Country (2021-2026) & (K Units) Table 226. Asia Prevent Meningitis Vaccine Sales by Country (2027-2032) & (K Units) Table 227. Asia Prevent Meningitis Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 228. Asia Prevent Meningitis Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 229. Japan Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 230. South Korea Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 231. India Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 232. Australia Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 233. China Taiwan Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 234. Southeast Asia Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 235. SAMEA Prevent Meningitis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 236. SAMEA Prevent Meningitis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 237. SAMEA Prevent Meningitis Vaccine Sales by Type (2021-2026) & (K Units) Table 238. SAMEA Prevent Meningitis Vaccine Sales by Type (2027-2032) & (K Units) Table 239. SAMEA Prevent Meningitis Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 240. SAMEA Prevent Meningitis Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 241. SAMEA Prevent Meningitis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 242. SAMEA Prevent Meningitis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 243. SAMEA Prevent Meningitis Vaccine Sales by Application (2021-2026) & (K Units) Table 244. SAMEA Prevent Meningitis Vaccine Sales by Application (2027-2032) & (K Units) Table 245. SAMEA Prevent Meningitis Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 246. SAMEA Prevent Meningitis Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 247. SAMEA Prevent Meningitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 248. SAMEA Prevent Meningitis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 249. SAMEA Prevent Meningitis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 250. SAMEA Prevent Meningitis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 251. SAMEA Prevent Meningitis Vaccine Sales by Country (2021-2026) & (K Units) Table 252. SAMEA Prevent Meningitis Vaccine Sales by Country (2027-2032) & (K Units) Table 253. SAMEA Prevent Meningitis Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 254. SAMEA Prevent Meningitis Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 255. Brazil Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 256. Argentina Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 257. Chile Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 258. Colombia Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 259. Peru Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 260. Saudi Arabia Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 261. Israel Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 262. UAE Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 263. Turkey Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 264. Iran Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 265. Egypt Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Table 266. Key Raw Materials Table 267. Raw Materials Key Suppliers Table 268. Prevent Meningitis Vaccine Distributors List Table 269. Prevent Meningitis Vaccine Customers List Table 270. Research Programs/Design for This Report Table 271. Authors List of This Report Table 272. Secondary Sources Table 273. Primary Sources List of Figures Figure 1. Prevent Meningitis Vaccine Image Figure 2. Global Prevent Meningitis Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prevent Meningitis Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Meningococcal AC Vaccine Image Figure 5. Meningococcal A Vaccine Image Figure 6. Meningococcal B Vaccine (MenB) Image Figure 7. Meningococcal Conjugate Vaccine (MenaCWY) Image Figure 8. Global Prevent Meningitis Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Prevent Meningitis Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 10. Baby Image Figure 11. Teenager Image Figure 12. Child Image Figure 13. Others Image Figure 14. Global Prevent Meningitis Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 16. Global Prevent Meningitis Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Prevent Meningitis Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2021-2032) Figure 19. Global Prevent Meningitis Vaccine Sales (2021-2032) & (K Units) Figure 20. Global Prevent Meningitis Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Prevent Meningitis Vaccine Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Prevent Meningitis Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Europe Prevent Meningitis Vaccine Sales YoY (2021-2032) & (K Units) Figure 24. China Prevent Meningitis Vaccine Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Prevent Meningitis Vaccine Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Prevent Meningitis Vaccine Sales YoY (2021-2032) & (K Units) Figure 27. Global Prevent Meningitis Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Prevent Meningitis Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Prevent Meningitis Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Prevent Meningitis Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Prevent Meningitis Vaccine Revenue Market Share by Type (2021-2032) Figure 33. Global Prevent Meningitis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Prevent Meningitis Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Prevent Meningitis Vaccine Sales Market Share by Type (2021-2032) Figure 36. Global Prevent Meningitis Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Prevent Meningitis Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Prevent Meningitis Vaccine Revenue Market Share by Application (2021-2032) Figure 39. Global Prevent Meningitis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Prevent Meningitis Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Prevent Meningitis Vaccine Sales Market Share by Application (2021-2032) Figure 42. North America Prevent Meningitis Vaccine Revenue Share by Type (2021-2032) Figure 43. North America Prevent Meningitis Vaccine Sales Share by Type (2021-2032) Figure 44. North America Prevent Meningitis Vaccine Revenue Share by Application (2021-2032) Figure 45. North America Prevent Meningitis Vaccine Sales Share by Application (2021-2032) Figure 46. North America Prevent Meningitis Vaccine Revenue Share by Country (2021-2032) Figure 47. North America Prevent Meningitis Vaccine Sales Share by Country (2021-2032) Figure 48. Europe Prevent Meningitis Vaccine Revenue Share by Type (2021-2032) Figure 49. Europe Prevent Meningitis Vaccine Sales Share by Type (2021-2032) Figure 50. Europe Prevent Meningitis Vaccine Revenue Share by Application (2021-2032) Figure 51. Europe Prevent Meningitis Vaccine Sales Share by Application (2021-2032) Figure 52. Europe Prevent Meningitis Vaccine Revenue Share by Country (2021-2032) Figure 53. Europe Prevent Meningitis Vaccine Sales Share by Country (2021-2032) Figure 54. China Prevent Meningitis Vaccine Revenue Share by Type (2021-2032) Figure 55. China Prevent Meningitis Vaccine Sales Share by Type (2021-2032) Figure 56. China Prevent Meningitis Vaccine Revenue Share by Application (2021-2032) Figure 57. China Prevent Meningitis Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Prevent Meningitis Vaccine Revenue Share by Type (2021-2032) Figure 59. Asia Prevent Meningitis Vaccine Sales Share by Type (2021-2032) Figure 60. Asia Prevent Meningitis Vaccine Revenue Share by Application (2021-2032) Figure 61. Asia Prevent Meningitis Vaccine Sales Share by Application (2021-2032) Figure 62. Asia Prevent Meningitis Vaccine Revenue Share by Country (2021-2032) Figure 63. Asia Prevent Meningitis Vaccine Sales Share by Country (2021-2032) Figure 64. SAMEA Prevent Meningitis Vaccine Revenue Share by Type (2021-2032) Figure 65. SAMEA Prevent Meningitis Vaccine Sales Share by Type (2021-2032) Figure 66. SAMEA Prevent Meningitis Vaccine Revenue Share by Application (2021-2032) Figure 67. SAMEA Prevent Meningitis Vaccine Sales Share by Application (2021-2032) Figure 68. SAMEA Prevent Meningitis Vaccine Revenue Share by Country (2021-2032) Figure 69. SAMEA Prevent Meningitis Vaccine Sales Share by Country (2021-2032) Figure 70. Prevent Meningitis Vaccine Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Prevent Meningitis Vaccine Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Meningococcal AC Vaccine
  • Meningococcal A Vaccine
  • Meningococcal B Vaccine (MenB)
  • Meningococcal Conjugate Vaccine (MenaCWY)
Applications
  • Baby
  • Teenager
  • Child
  • Others
Companies covered
  • GSK
  • China National Biotec Group
  • Zhejiang Tianyuan
  • Sanofi Pasteur
  • Novartis
  • Merck
  • Tianjin CanSino Biotechnology
  • Pfizer
  • Hualan Bio
  • Beijing Tiantan Biological
  • Baxter International
  • Zhifei
  • Wyeth Pharmaceuticals, Inc
  • Walvax
  • Serum Institute of India
  • JN International Medical Corporation
  • CSL Behring
  • Bio-Med

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Prevent Meningitis Vaccine Market by Type
  3. 1.2.1 Global Prevent Meningitis Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Meningococcal AC Vaccine
  5. 1.2.3 Meningococcal A Vaccine
  6. 1.2.4 Meningococcal B Vaccine (MenB)
  7. 1.2.5 Meningococcal Conjugate Vaccine (MenaCWY)
  8. 1.3 Prevent Meningitis Vaccine Market by Application
  9. 1.3.1 Global Prevent Meningitis Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Baby
  11. 1.3.3 Teenager
  12. 1.3.4 Child
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Prevent Meningitis Vaccine Market Dynamics
  1. 2.1 Prevent Meningitis Vaccine Industry Trends
  2. 2.2 Prevent Meningitis Vaccine Industry Drivers
  3. 2.3 Prevent Meningitis Vaccine Industry Opportunities and Challenges
  4. 2.4 Prevent Meningitis Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Prevent Meningitis Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Prevent Meningitis Vaccine Revenue by Region
  3. 3.2.1 Global Prevent Meningitis Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Prevent Meningitis Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Prevent Meningitis Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Prevent Meningitis Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Prevent Meningitis Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Prevent Meningitis Vaccine Sales by Region
  9. 3.4.1 Global Prevent Meningitis Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Prevent Meningitis Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Prevent Meningitis Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Prevent Meningitis Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Prevent Meningitis Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Prevent Meningitis Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Prevent Meningitis Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Prevent Meningitis Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Prevent Meningitis Vaccine Sales by Manufacturers
  6. 4.2.1 Global Prevent Meningitis Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Prevent Meningitis Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Prevent Meningitis Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Prevent Meningitis Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Prevent Meningitis Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Prevent Meningitis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Prevent Meningitis Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Prevent Meningitis Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Prevent Meningitis Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Prevent Meningitis Vaccine Tier 1, Tier 2, and Tier 3
5 Prevent Meningitis Vaccine Market by Type
  1. 5.1 Global Prevent Meningitis Vaccine Revenue by Type
  2. 5.1.1 Global Prevent Meningitis Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Prevent Meningitis Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Prevent Meningitis Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Prevent Meningitis Vaccine Sales by Type
  6. 5.2.1 Global Prevent Meningitis Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prevent Meningitis Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Prevent Meningitis Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Prevent Meningitis Vaccine Price by Type
6 Prevent Meningitis Vaccine Market by Application
  1. 6.1 Global Prevent Meningitis Vaccine Revenue by Application
  2. 6.1.1 Global Prevent Meningitis Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Prevent Meningitis Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Prevent Meningitis Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Prevent Meningitis Vaccine Sales by Application
  6. 6.2.1 Global Prevent Meningitis Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Prevent Meningitis Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Prevent Meningitis Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Prevent Meningitis Vaccine Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Prevent Meningitis Vaccine Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 China National Biotec Group
  8. 7.2.1 China National Biotec Group Company Information
  9. 7.2.2 China National Biotec Group Business Overview
  10. 7.2.3 China National Biotec Group Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 China National Biotec Group Prevent Meningitis Vaccine Product Portfolio
  12. 7.2.5 China National Biotec Group Recent Developments
  13. 7.3 Zhejiang Tianyuan
  14. 7.3.1 Zhejiang Tianyuan Company Information
  15. 7.3.2 Zhejiang Tianyuan Business Overview
  16. 7.3.3 Zhejiang Tianyuan Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Zhejiang Tianyuan Prevent Meningitis Vaccine Product Portfolio
  18. 7.3.5 Zhejiang Tianyuan Recent Developments
  19. 7.4 Sanofi Pasteur
  20. 7.4.1 Sanofi Pasteur Company Information
  21. 7.4.2 Sanofi Pasteur Business Overview
  22. 7.4.3 Sanofi Pasteur Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sanofi Pasteur Prevent Meningitis Vaccine Product Portfolio
  24. 7.4.5 Sanofi Pasteur Recent Developments
  25. 7.5 Novartis
  26. 7.5.1 Novartis Company Information
  27. 7.5.2 Novartis Business Overview
  28. 7.5.3 Novartis Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Novartis Prevent Meningitis Vaccine Product Portfolio
  30. 7.5.5 Novartis Recent Developments
  31. 7.6 Merck
  32. 7.6.1 Merck Company Information
  33. 7.6.2 Merck Business Overview
  34. 7.6.3 Merck Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Merck Prevent Meningitis Vaccine Product Portfolio
  36. 7.6.5 Merck Recent Developments
  37. 7.7 Tianjin CanSino Biotechnology
  38. 7.7.1 Tianjin CanSino Biotechnology Company Information
  39. 7.7.2 Tianjin CanSino Biotechnology Business Overview
  40. 7.7.3 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product Portfolio
  42. 7.7.5 Tianjin CanSino Biotechnology Recent Developments
  43. 7.8 Pfizer
  44. 7.8.1 Pfizer Company Information
  45. 7.8.2 Pfizer Business Overview
  46. 7.8.3 Pfizer Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer Prevent Meningitis Vaccine Product Portfolio
  48. 7.8.5 Pfizer Recent Developments
  49. 7.9 Hualan Bio
  50. 7.9.1 Hualan Bio Company Information
  51. 7.9.2 Hualan Bio Business Overview
  52. 7.9.3 Hualan Bio Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Hualan Bio Prevent Meningitis Vaccine Product Portfolio
  54. 7.9.5 Hualan Bio Recent Developments
  55. 7.10 Beijing Tiantan Biological
  56. 7.10.1 Beijing Tiantan Biological Company Information
  57. 7.10.2 Beijing Tiantan Biological Business Overview
  58. 7.10.3 Beijing Tiantan Biological Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Beijing Tiantan Biological Prevent Meningitis Vaccine Product Portfolio
  60. 7.10.5 Beijing Tiantan Biological Recent Developments
  61. 7.11 Baxter International
  62. 7.11.1 Baxter International Company Information
  63. 7.11.2 Baxter International Business Overview
  64. 7.11.3 Baxter International Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Baxter International Prevent Meningitis Vaccine Product Portfolio
  66. 7.11.5 Baxter International Recent Developments
  67. 7.12 Zhifei
  68. 7.12.1 Zhifei Company Information
  69. 7.12.2 Zhifei Business Overview
  70. 7.12.3 Zhifei Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Zhifei Prevent Meningitis Vaccine Product Portfolio
  72. 7.12.5 Zhifei Recent Developments
  73. 7.13 Wyeth Pharmaceuticals, Inc
  74. 7.13.1 Wyeth Pharmaceuticals, Inc Company Information
  75. 7.13.2 Wyeth Pharmaceuticals, Inc Business Overview
  76. 7.13.3 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product Portfolio
  78. 7.13.5 Wyeth Pharmaceuticals, Inc Recent Developments
  79. 7.14 Walvax
  80. 7.14.1 Walvax Company Information
  81. 7.14.2 Walvax Business Overview
  82. 7.14.3 Walvax Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Walvax Prevent Meningitis Vaccine Product Portfolio
  84. 7.14.5 Walvax Recent Developments
  85. 7.15 Serum Institute of India
  86. 7.15.1 Serum Institute of India Company Information
  87. 7.15.2 Serum Institute of India Business Overview
  88. 7.15.3 Serum Institute of India Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Serum Institute of India Prevent Meningitis Vaccine Product Portfolio
  90. 7.15.5 Serum Institute of India Recent Developments
  91. 7.16 JN International Medical Corporation
  92. 7.16.1 JN International Medical Corporation Company Information
  93. 7.16.2 JN International Medical Corporation Business Overview
  94. 7.16.3 JN International Medical Corporation Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 JN International Medical Corporation Prevent Meningitis Vaccine Product Portfolio
  96. 7.16.5 JN International Medical Corporation Recent Developments
  97. 7.17 CSL Behring
  98. 7.17.1 CSL Behring Company Information
  99. 7.17.2 CSL Behring Business Overview
  100. 7.17.3 CSL Behring Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 CSL Behring Prevent Meningitis Vaccine Product Portfolio
  102. 7.17.5 CSL Behring Recent Developments
  103. 7.18 Bio-Med
  104. 7.18.1 Bio-Med Company Information
  105. 7.18.2 Bio-Med Business Overview
  106. 7.18.3 Bio-Med Prevent Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Bio-Med Prevent Meningitis Vaccine Product Portfolio
  108. 7.18.5 Bio-Med Recent Developments
8 North America
  1. 8.1 North America Prevent Meningitis Vaccine Market Size by Type
  2. 8.1.1 North America Prevent Meningitis Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Prevent Meningitis Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Prevent Meningitis Vaccine Price by Type (2021-2032)
  5. 8.2 North America Prevent Meningitis Vaccine Market Size by Application
  6. 8.2.1 North America Prevent Meningitis Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Prevent Meningitis Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Prevent Meningitis Vaccine Price by Application (2021-2032)
  9. 8.3 North America Prevent Meningitis Vaccine Market Size by Country
  10. 8.3.1 North America Prevent Meningitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Prevent Meningitis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Prevent Meningitis Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Prevent Meningitis Vaccine Market Size by Type
  2. 9.1.1 Europe Prevent Meningitis Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Prevent Meningitis Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Prevent Meningitis Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Prevent Meningitis Vaccine Market Size by Application
  6. 9.2.1 Europe Prevent Meningitis Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Prevent Meningitis Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Prevent Meningitis Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Prevent Meningitis Vaccine Market Size by Country
  10. 9.3.1 Europe Prevent Meningitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Prevent Meningitis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Prevent Meningitis Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Prevent Meningitis Vaccine Market Size by Type
  2. 10.1.1 China Prevent Meningitis Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Prevent Meningitis Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Prevent Meningitis Vaccine Price by Type (2021-2032)
  5. 10.2 China Prevent Meningitis Vaccine Market Size by Application
  6. 10.2.1 China Prevent Meningitis Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Prevent Meningitis Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Prevent Meningitis Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Prevent Meningitis Vaccine Market Size by Type
  2. 11.1.1 Asia Prevent Meningitis Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Prevent Meningitis Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Prevent Meningitis Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Prevent Meningitis Vaccine Market Size by Application
  6. 11.2.1 Asia Prevent Meningitis Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Prevent Meningitis Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Prevent Meningitis Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Prevent Meningitis Vaccine Market Size by Country
  10. 11.3.1 Asia Prevent Meningitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Prevent Meningitis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Prevent Meningitis Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Prevent Meningitis Vaccine Market Size by Type
  2. 12.1.1 SAMEA Prevent Meningitis Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Prevent Meningitis Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Prevent Meningitis Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Prevent Meningitis Vaccine Market Size by Application
  6. 12.2.1 SAMEA Prevent Meningitis Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Prevent Meningitis Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Prevent Meningitis Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Prevent Meningitis Vaccine Market Size by Country
  10. 12.3.1 SAMEA Prevent Meningitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Prevent Meningitis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Prevent Meningitis Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Prevent Meningitis Vaccine Value Chain Analysis
  2. 13.1.1 Prevent Meningitis Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Prevent Meningitis Vaccine Production Mode & Process
  6. 13.2 Prevent Meningitis Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Prevent Meningitis Vaccine Distributors
  9. 13.2.3 Prevent Meningitis Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst